Venture Capital

Following its Verinext acquisition, Arctiq is absorbing Atlassian powerhouse Forty8Fifty Labs, a key move in its strategy to dominate enterprise IT.

Backed by Intel Capital, Israeli startup Q-Factor claims an architectural leap in neutral atom tech to solve quantum computing's biggest hurdle: scale.

With a $137M war chest, Sidewinder Therapeutics is advancing a new class of ultra-precise cancer drugs aimed at tumors that have long evaded treatment.

The women-only agency expands into tennis, adding Grand Slam champ Sloane Stephens and signaling a new model for athlete representation and ownership.

A new report puts Switzerland and Singapore above the US and UK, arguing that institutional strength, not economic scale, is the key to investor safety.

Amid industry-wide financial strain, Kurin's simple device for preventing blood culture contamination delivers record growth by saving hospitals money and lives.

Memory giant SK hynix invests in Semidynamics, backing a radical new chip design that tackles AI's biggest bottleneck and aims to slash the cost of AI.

Hemispherian launches a landmark trial for GLIX1, a first-in-class therapy aiming to selectively destroy glioblastoma cells where others have failed.

Configit's upcoming summit highlights how CLM provides the data foundation for manufacturers to master mass customization and successfully deploy AI.

Baseload Capital's new kids' book uses a character named 'Fossi' to explain the complex shift from fossil fuels to renewables like geothermal energy.

With a massive $750M boost to its share buyback, Nutanix underscores its financial strength and bets on its future in hybrid multicloud and enterprise AI.

EDERRA's new partnership with Cepham signals a shift in wellness, blending brand transparency with manufacturing science to lead the functional food market.

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.

With its Q1 earnings call on May 7, STARZ faces investor scrutiny on subscriber growth, content strategy, and its path to profitability post-spinoff.

Following positive safety data, Phanes Therapeutics expands trials for spevatamig, a first-in-class antibody targeting two cancer pathways at once.

A new holding company from Rise8's founder offers an alternative to VC, aiming to scale mission-critical software without sacrificing founder autonomy.

Following a viral two-hour sellout, Rachel Mansfield's cadootz! has secured over $3M to expand its ultra-clean kids' crackers into major retail.

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

Cybersecurity firm Minimus appoints elite tech lawyer Yael Nardi as CBO, signaling a radical new "operational powerhouse" strategy to dominate the market.

As AI chatbots transform how renters find apartments, one VC firm is betting on the startups that will help properties stay visible in a post-search world.